SingHealth Polyclinics
Singapore, 150167
NCT Number: NCT07399912
This study is testing a new app called ENHANCe, which is designed to help family doctors manage patients with high blood pressure using readings taken at home.
Interested in participating?
Request Info21 year and older
All sexes
Interventional
Not applicable
Singapore, 150167
The researchers want to find out if the app is easy to use in everyday clinic settings, whether doctors find it helpful and are willing to use it, and if it helps improve care. The study will involve 16 doctors and 100 patients with high blood pressure, split into two groups at two clinics. One group will use the ENHANCe app, which can read blood pressure data from different sources-including handwritten notes-and give doctors advice based on that information. The other group will receive regular care without the app. Over six months, researchers will collect feedback from doctors through surveys and group discussions at the end of the study. They'll also track how many people complete the study, how long clinic visits take, whether doctors follow the app's advice, and how well patients' blood pressure is controlled. The goal is to see if the app can help doctors make faster, better decisions and improve health outcomes for people managing their blood pressure at home.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For primary care physicians:
For patients:
Exclusion criteria
for patients:
ENHANCe app is a prototype; it is a smartphone based clinical decision support (CDS) tool to manage patients with hypertension using their home blood pressure. The app will scan patients' home BP records from paper or mobile phone, and provide a recommendation to the doctor on how to manage their blood pressure. The patient will not need to use the device during the study period. However, the recommendation from the ENHANCe app will be available to the doctor to manage your blood pressure during the study period if the patient is in the intervention group.
All patients will have access to online educational resources throughout the study. After recruitment, they will receive a nurse-led education on HBP monitoring. The research team will train all primary care physicians (PCPs) on managing patients with hypertension using HBP records.
Physicians manage patients using HBP records at their discretion
Time frame: 6 months
Participants agreeable to participate in the study
Time frame: 6 months
Proportion of PCPs who agree with the CDSS recommendation in the two groups
Time frame: 6 months
Proportion of participants who withdrew
Time frame: 6 months
Proportion of participants who completed the intervention
Time frame: 6 months
Proportion of adverse events reported in the two groups
Time frame: 6 months
Consult time in the groups
Time frame: 6 months
Ease of home blood pressure record assessment among PCPS in the two arms
Time frame: 6 months
Proportion of ENHANCe recommendations followed by the PCPs among the two groups
Time frame: 6 months
Blood pressure control status among patients in the two groups
SingHealth Polyclinics
Other
Engaging Home-monitored Assessment to Navigate Clinical Decision-making -The ENHANCe Study
Acronym: ENHANCe
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06205628
Cardiovascular Diseases, Essential Hypertension
Adelaide, South Australia, Australia
View Trial DetailsNCT05546931
Adherence, Medication, Behavior
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT03480217
Cardiovascular Diseases, Essential Hypertension
New York, United States
View Trial DetailsNCT03503773
Cardiovascular Diseases, Essential Hypertension
Brussels, Belgium
View Trial Details